The role of insulin resistance in MASLD among women with PCOS is supported by studies showing that improving insulin sensitivity—through weight loss or pharmacologic agents—ameliorates reproductive, metabolic, and hyperandrogenic symptoms. The gene discussed is INS; the disease is polycystic ovary syndrome.